Laquinimod, a once-daily oral drug in development for the treatment of relapsing–remitting multiple sclerosis
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1586/ecp.12.12
Reference41 articles.
1. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications
2. Pathophysiology of inflammation and tissue injury in multiple sclerosis: What are the targets for therapy
3. Escalating Immunotherapy of Multiple Sclerosis
4. Development of oral immunomodulatory agents in the management of multiple sclerosis
5. Emerging Oral Therapies in Multiple Sclerosis
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies;Frontiers in Chemistry;2021-09-22
2. The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator;Clinical Pharmacology in Drug Development;2020-04
3. The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women;European Journal of Clinical Pharmacology;2018-09-06
4. Recent advances in the management of systemic lupus erythematosus;F1000Research;2018-06-29
5. A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease;Clinical Pharmacology in Drug Development;2018-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3